Gene · 4831
Papers1,736
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,736
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Influence of Extracellular Vesicles on Lung Stromal Cells during Breast Cancer Metastasis. | Int J Mol Sci | 2023 | 37511559 | PubTator, text mining | PubMed |
| KCa2 and KCa3.1 Channels in the Airways: A New Therapeutic Target. | Biomedicines | 2023 | 37509419 | PubTator, text mining | PubMed |
| Chemical Recycling of Flexible Polyurethane Foams by Aminolysis to Recover High-Quality Polyols. | ACS Sustain Chem Eng | 2023 | 37502771 | PubTator, text mining | PubMed |
| Cellular dynamics in tumour microenvironment along with lung cancer progression underscore spatial and evolutionary heterogeneity of neutrophil. | Clin Transl Med | 2023 | 37491740 | PubTator, text mining | PubMed |
| Multicomponent Oxidative Nitrile Thiazolidination Reaction for Selective Modification of N-terminal Dimethylation Posttranslational Modification. | J Am Chem Soc | 2023 | 37486086 | PubTator, text mining | PubMed |
| PUM1 Promotes Tumor Progression by Activating DEPTOR-Meditated Glycolysis in Gastric Cancer. | Adv Sci (Weinh) | 2023 | 37469018 | PubTator, text mining | PubMed |
| Rewired Metabolism Caused by the Oncogenic Deregulation of MYC as an Attractive Therapeutic Target in Cancers. | Cells | 2023 | 37443779 | PubTator, text mining | PubMed |
| Pathogen and human NDPK-proteins promote AML cell survival via monocyte NLRP3-inflammasome activation. | PLoS One | 2023 | 37418424 | PubTator, text mining | PubMed |
| Simultaneous multifunctional transcriptome engineering by CRISPR RNA scaffold. | Nucleic Acids Res | 2023 | 37395412 | PubTator, text mining | PubMed |
| Optimizing single cell proteomics using trapped ion mobility spectrometry for label-free experiments. | Analyst | 2023 | 37395315 | PubTator, text mining | PubMed |
| Application of codon usage and context analysis in genes up- or down-regulated in neurodegeneration and cancer to combat comorbidities. | Front Mol Neurosci | 2023 | 37383425 | PubTator, text mining | PubMed |
| In vivo dynamics and regulation of DNA G-quadruplex structures in mammals. | Cell Biosci | 2023 | 37381029 | PubTator, text mining | PubMed |
| Mechanisms of action of NME metastasis suppressors - a family affair. | Cancer Metastasis Rev | 2023 | 37353690 | PubTator, text mining | PubMed |
| Urethane functions can reduce metal salts under hydrothermal conditions: synthesis of noble metal nanoparticles on flexible sponges applied in semi-automated organic reduction. | J Mater Chem A Mater | 2023 | 37346738 | PubTator, text mining | PubMed |
| Short-Term TERT Inhibition Impairs Cellular Proliferation via a Telomere Length-Independent Mechanism and Can Be Exploited as a Potential Anticancer Approach. | Cancers (Basel) | 2023 | 37345011 | PubTator, text mining | PubMed |
| Integrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progression. | Respir Res | 2023 | 37344825 | PubTator, text mining | PubMed |
| Live cell imaging of DNA and RNA with fluorescent signal amplification and background reduction techniques. | Front Cell Dev Biol | 2023 | 37342234 | PubTator, text mining | PubMed |
| Piezoresistive Behavior of a Conductive Polyurethane Based-Foam for Real-Time Structural Monitoring. | Sensors (Basel) | 2023 | 37299890 | PubTator, text mining | PubMed |
| A Unique Mode of Coenzyme A Binding to the Nucleotide Binding Pocket of Human Metastasis Suppressor NME1. | Int J Mol Sci | 2023 | 37298313 | PubTator, text mining | PubMed |
| An all-in-one nanoprinting approach for the synthesis of a nanofilm library for unclonable anti-counterfeiting applications. | Nat Nanotechnol | 2023 | 37277535 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4831/papers?page=7